Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ISET 25: Drug Delivery Devices: Paclitaxel Drug-Coated Balloons and Drug-Eluting Stents
Author(s): Marianne Brodmann Added: 1 year ago
ISET 2025 - How have drug delivery devices changed over the years, and what are the novel technologies and therapeutic agents?Dr Marianne Brodmann (Medical University of Graz, AT) joins us onsite at ISET 2025 to discuss the current landscape of drug delivery devices, from paclitaxel drug-coated balloons to drug-eluting stents. Dr Brodmann discusses evolving technologies, including bioresorbable… View more

Intervention

Vascular Disease and Surgery
Drug-coated Balloon Angioplasty in Sri Lanka
Author(s): Yanushka Herath , Judy Ranaweera , Thisal Semina , et al Added: 6 months ago

Intervention

Prevention & Chronic Conditions
LINC 2025: 12-Month Amputation and Readmission Rates from TRUE-PTX
Author(s): Marianne Brodmann Added: 1 year ago
LINC 2025 - 12-month amputation and readmission rates from the TRUE-PTX study suggests endovascular revascularisation for peripheral artery disease (PAD) with drug-eluting devices lead to better outcomes than with bare device therapies.Dr Marianne Brodmann (Medical University of Graz, AT) joins us to discuss the TRUE-PTX study evaluating a database of patients in the US with PAD who have recieved… View more

Intervention

Vascular Disease and Surgery
ESC 25: SWEDEPAD 1 and 2
Author(s): Marten Falkenberg , Joakim Nordanstig Added: 9 months ago
ESC Congress 2025 - Paclitaxel-coated devices in critical limb threatening ischemia were not effective in preventing amputation, nor improving quality-of-life in intermittent claudication.Dr Mårten Falkenberg (Sahlgrenska University Hospital, Gothenburg, SE) and Prof Joakim Nordanstig (Sahlgrenska University Hospital, Gothenburg, SE) join us to discuss findings from the SWEDEPAD 1 and 2 parallel… View more

Intervention

Vascular Disease and Surgery
TCT 25: LIFE-BTK: The Esprit™ BTK Drug-Eluting Resorbable Scaffold for Infrapopliteal Lesions
Author(s): Sahil Parikh Added: 7 months ago
TCT 2025 - Three-year findings from LIFE-BTK show the Esprit™ BTK scaffold is a durable and effective treatment option for patients with CLTI.Dr Sahil Parikh (Columbia University Vagelos College of Physicians & Surgeons, New York, US) joins us to share the three-year findings from LIFE-BTK (NCT04227899). The randomized controlled trial aimed to evaluate the safety and efficacy of the Esprit™ BTK… View more

Intervention

Vascular Disease and Surgery
Ep 5: What is the Difference Between the Two Drugs in the Context of DCB?
Added: 1 year ago
Join host Dr Rasha Al-Lamee in this exciting new episode, as she is joined by Prof Michael Joner and Prof Bruno Scheller to delve into the distinctive properties of two commonly utilised drugs in the field of DCB.Increase your understanding of these products by tuning in to this enlightening 15-minute discussion, where you will gain insights on key features and the safety profile, provided with… View more

Intervention
Market Watch With Abbott: Optimising PCI Workflow, Imaging and AI
Author(s): Brad Wilson , Ethan Korngold Added: 3 days ago
In this Market Watch interview, Brad Wilson speaks with Dr Ethan Korngold, Chief Medical Officer and Divisional Vice President, Medical Affairs for Abbott Vascular, about how percutaneous coronary intervention is evolving beyond the device toward procedural precision, imaging and intelligent decision support.Dr Korngold frames the central challenge of contemporary PCI as matching the right… View more

Intervention
Research Area(s) / Expertise:

Cardio-oncology

Heart Failure

 Job title: Assistant Professor
Dr Giselle Melendez is anAssistant Professor atWake Forest University School of Medicine, Winston-Salem, US.Commencing her scientific career at the University of South Carolina School of Medicine, Dr. Melendez focused on molecular mediators of myocardial extracellular matrix remodeling and heart failure. Notably, her research uncovered vital insights into inflammatory cytokines TNF-α, IL-6, and… View more
Giuseppe Andò
Research Area(s) / Expertise:

Intervention

Anticoagulation

Heart Failure

 Job title: Associate Professor of Cardiovascular Medicine, Senior Consultant Interventional Cardiologist
Giuseppe Andò, MD PhD is Associate Professor ofCardiovascular Medicineat Messina University and Senior Consultant Interventional Cardiologist at Messina University Hospital.Prof. Andò has been elected a Fellow and serves in the Scientific Board of the Italian Society of Interventional Cardiology (SICI-GISE) and has been appointed a Scholar in Cardiology and a Senior Fellow (FISC) of the Italian… View more